Prognostic factors and treatment outcome in childhood acute lymphoblastic leukemia

نویسندگان

چکیده

Introduction. Acute lymphoblastic leukemia is ? malignant, clonal proliferation of B or T lymphocyte precursors. Prognostic factors play an important role in the treatment this disease. The objective study was to determine whether individual clinical and laboratory parameters may have a predictive significance for relapse disease outcome. Material Methods. A retrospective included 53 patients with acute treated at Institute Child Youth Health Care Vojvodina. following were examined: gender, age diagnosis, initial white blood cell count, peripheral blast percentage, bone marrow prednisone response on day 8 treatment, immunophenotypic characteristics leukemic blasts, infiltration central nervous system. Relapses lethal outcomes analyzed as well. Results. mean diagnosis 6.4 7.8 years. associated poor outcome were: over 10 years, mature leukemia, system involvement. Relapse found 6 children (11.3%). Lethal recorded 7 (13.2%). Conclusion. Treatment childhood should be based prognostic each patient. results are consistent current literature.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Relapsed childhood acute lymphoblastic leukemia in the Nordic countries: prognostic factors, treatment and outcome.

Relapse is the main reason for treatment failure in childhood acute lymphoblastic leukemia. Despite improvements in the up-front therapy, survival after relapse is still relatively poor, especially for high-risk relapses. The aims of this study were to assess outcomes following acute lymphoblastic leukemia relapse after common initial Nordic Society of Paediatric Haematology and Oncology protoc...

متن کامل

Hyperleukocytosis in childhood acute lymphoblastic leukemia: complications and treatment outcome.

Hyperleukocytosis, defined as a peripheral leukocyte count ≥ 100x109/L, is seen in 5-20% of newly diagnosed cases of childhood leukemia and is a poor prognostic factor. In this study, we aimed to examine the presenting clinical and laboratory features, complications, and treatment outcome of 47 children with acute lymphoblastic leukemia (ALL) and hyperleukocytosis who were diagnosed and treated...

متن کامل

Childhood Acute Lymphoblastic Leukemia: Currently Applied Prognostic Factors

Several clinical and biologic factors have been found to be significant predictors of outcome in childhood acute lymphoblastic leukemia (ALL), including age, presenting leukocyte count, immunophenotype, recurrent chromosomal abnormalities, and response to initial therapy as assessed by light microscopy as well as more sensitive measures of submicroscopic disease. Over the last several decades, ...

متن کامل

Central nervous system disease in childhood acute lymphoblastic leukemia: prognostic factors and results of treatment.

In the five Nordic countries, 808 children 1 to 15 years of age (428 boys, 380 girls) were diagnosed with non-B acute lymphoblastic leukemia (ALL) from July 1981 through June 1986. Complete remission was achieved in 770 children (95%). Central nervous system (CNS) involvement at diagnosis was noticed in 34 children, of whom 26 achieved remission. Of these 26 patients 11 subsequently relapsed, 5...

متن کامل

Prognostic factors and treatment of pediatric acute lymphoblastic leukemia

The event-free survival (EFS) for pediatric acute lymphoblastic leukemia (ALL) has shown remarkable improvement in the past several decades. In Korea also, a recent study showed 10-year EFS of 78.5%. Much of the improved outcome for pediatric ALL stems from the accurate identification of prognostic factors, the designation of risk group based on these factors, and treatment of appropriate durat...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Medicinski Pregled

سال: 2021

ISSN: ['0025-8105', '1820-7383']

DOI: https://doi.org/10.2298/mpns2110298d